Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

JanOne - 33 Year Stock Price History | JAN

Historical daily share price chart and data for JanOne since 1991 adjusted for splits and dividends. The latest closing stock price for JanOne as of April 18, 2024 is 3.70.
  • The all-time high JanOne stock closing price was 385.00 on April 01, 1993.
  • The JanOne 52-week high stock price is 4.08, which is 10.3% above the current share price.
  • The JanOne 52-week low stock price is 0.22, which is 94.1% below the current share price.
  • The average JanOne stock price for the last 52 weeks is 0.98.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
JanOne Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 1.6062 0.6072 3.8200 0.5000 3.7000 566.67%
2023 0.9212 1.4750 1.7700 0.3000 0.5550 -59.49%
2022 2.6705 4.1900 4.2500 1.3700 1.3700 -66.50%
2021 6.9359 4.4800 12.9900 3.8600 4.0900 -16.36%
2020 3.7607 3.0300 7.7900 2.0500 4.8900 65.20%
2019 3.3622 2.2940 6.0500 2.0900 2.9600 33.18%
2018 4.0333 5.4500 6.8500 1.8100 2.2226 -57.26%
2017 4.8653 5.5500 7.2500 3.0320 5.2000 -7.14%
2016 5.4496 5.1495 9.0000 3.3990 5.6000 6.67%
2015 8.6881 13.3250 15.1500 3.0430 5.2500 -61.82%
2014 15.8905 14.5000 21.1500 12.8000 13.7500 -4.18%
2013 11.4593 7.3000 18.1500 6.0000 14.3500 114.18%
2012 18.7799 27.1950 31.2500 5.7500 6.7000 -73.19%
2011 22.0932 16.5000 32.8500 15.9000 24.9910 47.01%
2010 14.5959 11.3500 19.5000 10.4500 17.0000 47.83%
2009 10.5053 15.3500 18.2500 5.3000 11.5000 -22.04%
2008 26.1198 44.2500 44.7000 11.0500 14.7505 -67.04%
2007 25.9886 11.0000 55.0000 10.5000 44.7500 316.28%
2006 17.8142 24.5000 32.5000 9.2500 10.7500 -56.12%
2005 19.9482 23.0000 30.0000 13.7500 24.5000 6.52%
2004 14.3826 13.7500 23.2500 10.2500 23.0000 67.27%
2003 8.2567 10.0000 13.7500 5.1000 13.7500 37.50%
2002 16.6869 20.0000 26.5000 8.1500 10.0000 -50.25%
2001 13.4060 6.2500 28.5000 5.0000 20.1000 221.60%
2000 9.4812 5.0000 15.6250 3.4350 6.2500 11.11%
1999 3.7541 3.1250 7.5000 2.5000 5.6250 50.00%
1998 9.8989 12.1900 20.0000 2.5000 3.7500 -66.67%
1997 13.9947 12.4000 20.0000 10.0000 11.2500 -9.27%
1996 63.2307 92.4000 97.6000 12.4000 12.4000 -86.58%
1995 108.4230 80.0000 140.0000 70.0000 92.4000 14.64%
1994 191.0119 280.0000 290.0000 75.0000 80.6000 -70.69%
1993 270.8941 297.6000 385.0000 160.0000 275.0000 -9.84%
1992 219.4000 170.0000 315.0000 170.0000 305.0000 79.41%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.031B $0.040B
JanOne is focused on developing treatments for diseases that cause severe pain. By alleviating pain at the source, JanOne aims to reduce the need for opioid prescriptions to treat disease associated pain that can lead to opioid abuse. The company is also exploring solutions for non-addictive pain medications. Its lead candidate JAN101 is for treating peripheral artery disease (PAD), a condition that affects over 8.5 million Americans. JAN101 demonstrated positive results in a Phase 2a clinical trial, and Phase 2b trials are expected to begin in early 2021. JanOne is dedicated to funding resources toward innovation, technology, and education for PAD, associated vascular conditions and neuropathic pain. JanOne continues to operate its legacy businesses under their current brand names, which are undergoing review to determine appropriate strategic alternatives.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $69.491B 28.56
Chugai Pharmaceutical (CHGCY) Japan $53.791B 23.36
Takeda Pharmaceutical (TAK) Japan $41.617B 6.74
Merck (MKGAF) Germany $20.517B 19.36
Astellas Pharma (ALPMY) Japan $17.119B 24.26
Shionogi (SGIOY) Japan $14.091B 12.19
Neurocrine Biosciences (NBIX) United States $13.257B 55.05
Sandoz Group AG (SDZNY) Switzerland $13.249B 0.00
United Therapeutics (UTHR) United States $11.073B 11.86
Catalent (CTLT) United States $10.127B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.554B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.747B 6.84
Revolution Medicines (RVMD) United States $6.064B 0.00
Ionis Pharmaceuticals (IONS) United States $5.963B 0.00
Orion OYJ (ORINY) Finland $5.081B 21.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.543B 0.00
Alpine Immune Sciences (ALPN) United States $4.225B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.063B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.791B 0.00
Indivior (INDV) United States $2.656B 12.35
Evotec AG (EVO) Germany $2.566B 0.00
Summit Therapeutics (SMMT) United States $2.505B 0.00
Corcept Therapeutics (CORT) United States $2.381B 24.21
Dyne Therapeutics (DYN) United States $2.139B 0.00
PTC Therapeutics (PTCT) United States $1.927B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.888B 19.51
Fusion Pharmaceuticals (FUSN) Canada $1.803B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.790B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.753B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.676B 9.93
Avadel Pharmaceuticals (AVDL) Ireland $1.629B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.588B 27.79
Ardelyx (ARDX) United States $1.524B 0.00
4D Molecular Therapeutics (FDMT) United States $1.294B 0.00
Pacira BioSciences (PCRX) United States $1.245B 12.39
Soleno Therapeutics (SLNO) United States $1.230B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.197B 11.25
Xencor (XNCR) United States $1.166B 0.00
Collegium Pharmaceutical (COLL) United States $1.159B 7.13
Ocular Therapeutix (OCUL) United States $1.127B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.081B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.944B 0.00
Cronos Group (CRON) Canada $0.924B 0.00
Cassava Sciences (SAVA) United States $0.920B 0.00
ARS Pharmaceuticals (SPRY) United States $0.874B 0.00
USANA Health Sciences (USNA) United States $0.828B 13.03
Relay Therapeutics (RLAY) United States $0.815B 0.00
Enliven Therapeutics (ELVN) United States $0.810B 0.00
Sage Therapeutics (SAGE) United States $0.756B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.710B 0.00
Savara (SVRA) United States $0.685B 0.00
ProKidney (PROK) United States $0.651B 0.00
Silence Therapeutics (SLN) United Kingdom $0.645B 0.00
Siga Technologies (SIGA) United States $0.605B 8.96
Lyell Immunopharma (LYEL) United States $0.605B 0.00
Verve Therapeutics (VERV) United States $0.564B 0.00
OmniAb (OABI) United States $0.560B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.558B 0.00
Korro Bio (KRRO) United States $0.556B 0.00
Exscientia (EXAI) United Kingdom $0.522B 0.00
Altimmune (ALT) United States $0.499B 0.00
KalVista Pharmaceuticals (KALV) United States $0.491B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.462B 0.00
Larimar Therapeutics (LRMR) United States $0.450B 0.00
Tourmaline Bio (TRML) United States $0.428B 0.00
Harrow (HROW) United States $0.418B 0.00
Heron Therapeutics (HRTX) United States $0.416B 0.00
Lexeo Therapeutics (LXEO) United States $0.404B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.390B 0.00
Bioventus (BVS) United States $0.372B 0.00
Organogenesis (ORGO) United States $0.368B 69.75
Nature's Sunshine Products (NATR) United States $0.354B 19.80
Esperion Therapeutics (ESPR) United States $0.349B 0.00
Lyra Therapeutics (LYRA) United States $0.323B 0.00
Fractyl Health (GUTS) United States $0.318B 0.00
ESSA Pharma (EPIX) Canada $0.313B 0.00
Metagenomi (MGX) United States $0.309B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.299B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.296B 0.00
Black Diamond Therapeutics (BDTX) United States $0.295B 0.00
Akebia Therapeutics (AKBA) United States $0.291B 0.00
Aquestive Therapeutics (AQST) United States $0.287B 0.00
Pyxis Oncology (PYXS) United States $0.281B 0.00
Adherex Technologies (FENC) United States $0.263B 0.00
Nanobiotix S.A (NBTX) France $0.254B 0.00
Telomir Pharmaceuticals (TELO) United States $0.251B 0.00
Xeris Biopharma Holdings (XERS) United States $0.250B 0.00
Nektar Therapeutics (NKTR) United States $0.248B 0.00
Foghorn Therapeutics (FHTX) United States $0.246B 0.00
Avita Medical (RCEL) United States $0.241B 0.00
Acrivon Therapeutics (ACRV) United States $0.234B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Prelude Therapeutics (PRLD) United States $0.230B 0.00
Conduit Pharmaceuticals (CDT) United States $0.216B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Zevra Therapeutics (ZVRA) United States $0.202B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.195B 0.00
Profound Medical (PROF) Canada $0.190B 0.00
Century Therapeutics (IPSC) United States $0.184B 0.00
MediWound (MDWD) Israel $0.166B 0.00
Karyopharm Therapeutics (KPTI) United States $0.159B 0.00
Achieve Life Sciences (ACHV) Canada $0.157B 0.00
Incannex Healthcare (IXHL) Australia $0.154B 0.00
Regulus Therapeutics (RGLS) United States $0.153B 0.00
VAXART, INC (VXRT) United States $0.151B 0.00
GlycoMimetics (GLYC) United States $0.147B 0.00
Elite Pharmaceuticals (ELTP) United States $0.145B 13.58
CytoDyn (CYDY) United States $0.145B 0.00
Relmada Therapeutics (RLMD) United States $0.141B 0.00
Inotiv (NOTV) United States $0.140B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.136B 2.86
Citius Pharmaceuticals (CTXR) United States $0.130B 0.00
FibroGen (FGEN) United States $0.125B 0.00
Eliem Therapeutics (ELYM) United States $0.123B 0.00
Cardiol Therapeutics (CRDL) Canada $0.119B 0.00
OptiNose (OPTN) United States $0.115B 0.00
ProPhase Labs (PRPH) United States $0.113B 0.00
Vivani Medical (VANI) United States $0.101B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.089B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
AlloVir (ALVR) United States $0.087B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.079B 0.00
Journey Medical (DERM) United States $0.077B 0.00
Assertio Holdings (ASRT) United States $0.074B 6.00
Tempest Therapeutics (TPST) United States $0.073B 0.00
Carisma Therapeutics (CARM) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
Mural Oncology (MURA) $0.064B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.059B 0.00
SCYNEXIS (SCYX) United States $0.054B 0.80
Gain Therapeutics (GANX) United States $0.052B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
Jaguar Animal Health (JAGX) United States $0.046B 0.00
Rafael Holdings (RFL) United States $0.044B 0.00
Unicycive Therapeutics (UNCY) United States $0.040B 0.00
NRx Pharmaceuticals (NRXP) United States $0.040B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
Viracta Therapeutics (VIRX) United States $0.037B 0.00
VYNE Therapeutics (VYNE) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Nutriband (NTRB) United States $0.033B 0.00
Protara Therapeutics (TARA) United States $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Lipocine (LPCN) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
DURECT (DRRX) United States $0.027B 0.00
Aptorum Group (APM) United Kingdom $0.026B 0.00
CERo Therapeutics Holdings (CERO) United States $0.024B 0.00
Oncternal Therapeutics (ONCT) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
Addex Therapeutics (ADXN) Switzerland $0.023B 0.00
Indaptus Therapeutics (INDP) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 10.47
MEI Pharma (MEIP) United States $0.022B 1.11
TherapeuticsMD (TXMD) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
Surrozen (SRZN) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.017B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
Inhibikase Therapeutics (IKT) United States $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Biomerica (BMRA) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Universe Pharmaceuticals INC (UPC) China $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.15
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 46.55